BackAcasti Pharma Overview

Acasti Pharma Accounts Payable

Track Acasti Pharma's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer average

Loading

Acasti Pharma Accounts Payable History

Loading

Acasti Pharma vs. peers: Accounts Payable Comparison

Loading

Acasti Pharma Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Acasti Pharma (ACST) FAQ

As of the most recent data (March 2026), ACST shows a accounts payable of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACST's accounts payable is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Acasti Pharma is outperforming or lagging.

Tracking ACST's accounts payable over time shows whether Acasti Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Acasti Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.

Acasti Pharma's accounts payable is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.